Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
Study sponsor: Can-Fite BioPharma
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2007-04Actual
Enrollment · participants254Actual
Source updated2023-09-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.